http://orcid.org/0000-0002-3322-0080
References
- Stich, A.; Ponte-Sucre, A.; Holzgrabe, U. Do We Need New Drugs against Human African Trypanosomiasis? Lancet Infect. Dis. 2013, 13, 733–734. DOI:10.1016/S1473-3099(13)70191-9.
- Astelbauer, F.; Walochnik, J. Antiprotozoal Compounds: State of the Art and New Developments. Int. J. Antimicrob. Agents. 2011, 38, 118–124. DOI:10.1016/j.ijantimicag.2011.03.004.
- Burri, C. Chemotherapy against Human African Trypanosomiasis: Is There a Road to Success. Parasitology. 2010, 137, 1987–1994. DOI:10.1017/S0031182010001137.
- Keiser, J.; Burri, C. Evaluation of Quinolone Derivatives for Antitrypanosomal Activity. Trop. Med. Int. Health. 2001, 6, 369–389. DOI:10.1046/j.1365-3156.2001.00713.x.
- Hiltensperger, G.; Jones, N. G.; Niedermeier, S.; Stich, A.; Kaiser, M.; Jung, J.; Puhl, S.; Damme, A.; Braunschweig, H.; Meinel, L.; et al. Synthesis and Structure-Activity Relationships of New Quinolone-Type Molecules against Trypanosoma brucei. J. Med. Chem. 2012, 55, 2538–2548. DOI:10.1021/jm101439s.
- Hiltensperger, G.; Hecht, N.; Kaiser, M.; Rybak, J.C.; Hoerst, A.; Dannenbauer, N.; Müller-Buschbaum, K.; Bruhn, H.; Esch, H.; Lehmann, L.; et al. Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity. Antimicrob. Agents Chemother. 2016, 60, 4442–4452. DOI:10.1128/AAC.01757-15.
- Fatondji, H. R.; Kpoviessi, S.; Gbaguidi, F.; Bero, J.; Hannaert, V.; Quetin-Leclercq, J.; Poupaert, J.; Moudachirou, M.; Coffi, G. Structure-Activity Relationship Study of Thiosemicarbazones on an African Trypanosome: Trypanosoma brucei Brucei. Med. Chem. Res. 2013, 22, 2151–2162. DOI:10.1007/s00044-012-0208-6.
- Abdolmaleki, A.; Ghasemi, J. B. Dual-Acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-Target Drugs: Lead Generation Approaches. Curr. Top. Med. Chem. 2017, 17, 1096–1114. DOI:10.2174/1568026616666160927151144.
- Kryshchyshyn, A.; Kaminskyy, D.; Grellier, P.; Lesyk, R. Trends in Research of Antitrypanosomal Agents among Synthetic Heterocycles. Eur. J. Med. Chem 2014, 85, 51–64. DOI:10.1016/j.ejmech.2014.07.092.
- Gazieva, G.A.; Kravchenko, A.N. Thiosemicarbazides in the Synthesis of Five- and Six-Membered Heterocyclic Compounds. Russ. Chem. Rev. 2012, 81, 494–523. DOI:10.1070/RC2012v081n06ABEH004235.
- Räz, B.; Iten, M.; Grether-Bühler, Y.; Kaminsky, R.; Brun, R. The Alamar Blue Assay to Determine Drug Sensitivity of African Trypanosomes (T. brucei Rhodesiense and T. brucei Gambiense) In Vitro. Acta Trop. 1997, 68, 139–147. DOI:10.1016/s0001-706x(97)00079-x.
- Schmidt, I.; Göllner, S.; Fusz, A.; Stich, A.; Kucharski, A.; Schirmeister, T.; Katzowitsch, E.; Bruhn, H.; Miliu, A.; Krauth-Siegel, R.L.; Holzgrabe, U. Bistacrines as Potential Antitrypanosomal Agents. Bioorg. Med. Chem. 2017, 25, 4526–4531. DOI:10.1016/j.bmc.2017.06.051.
- Baltz, T.; Baltz, D.; Giroud, C.; Crocket, J. Cultivation in a Semi-Defined Medium of Animal Infective Forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. Embo J. 1985, 4, 1273–1277. DOI:10.1002/j.1460-2075.1985.tb03772.x.
- Ahmed, S. A.; Gogal, R. M.; Walsh, J. E. A New Rapid and Simple Non-Radioactive Assay to Monitor and Determine the Proliferation of Lymphocytes: An Alternative to [3H]Thymidine Incorporation Assay. J. Immunol. Methods. 1994, 170, 211–224. DOI:10.1016/0022-1759(94)90396-4.